Cantley, James
Davenport, Aimee
Vetterli, Laurène
Nemes, Nandor J.
Whitworth, P. Tess
Boslem, Ebru
Thai, Le May
Mellett, Natalie
Meikle, Peter J.
Hoehn, Kyle L.
James, David E.
Biden, Trevor J.
Funding for this research was provided by:
University of Oxford
Article History
Received: 16 April 2018
Accepted: 22 August 2018
First Online: 17 October 2018
Duality of interest
: JC is a founder and shareholder of OxStem Beta, a company developing drugs for the treatment of diabetes. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.